Investigation for gastrointestinal mucosa and submucosa using new endoscopic imaging technology (Dual Red Imaging)

Not Applicable

• Conditions: Esophageal cancer, Esophageal intraepithelial neoplasia,gastric cancer, gastric adenoma, colorectal cancer, colorectal adenoma, Barrett' s esophageal cancer, ulcerative colitis, esophageal varices

• Registration Number: JPRN-UMIN000018309
• Lead Sponsor: Center for Research and Development of Minimally Invasive Treatment, Cancer Center, Keio University

Brief Summary

DRI improved easiness of hemostasis and dicreased psycological stress on hemostasis and time required for hemostasis. (Presentation at the 89th congress of the Japan Gastroenterological Endoscopy Society, May 2015)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-15
• Study Completion: 2022-01-07
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patient who has other disease which affect this study such as severe ulcer or inflammation. 2. The patient who judged that we were inappropriate to perform examination safely. 3. Patient that an agreement was not obtained.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Improvement of diagnosis precision: Detection for lesion, Diagnosis of depth of cancer invasion, Assessment for the severity of inflammation. 2.Improvement for visualization of thick blood vessel and bleeding point during ESD. Shortening of total ESD procedure time.